23andMe Funding & Investors

Mountain View, CA

Discover what 125+ personalized reports have to say about your ancestry, health, traits and more.

Total Amount Raised: $1,104,373,632

23andMe Funding Rounds

Post Ipo Equity
$250,000,000
Jun 16, 2021
Post Ipo Equity Investors
Casdin Capital
Fidelity Investments
Foresite Capital
Anne Wojcicki
Altimeter Capital
Richard Branson
IPO
Unknown
Jan 1, 2021
Series F
$82,500,000
Dec 28, 2020
Series F Investors
NewView Capital Management
Sequoia Capital
Pegasus Tech Ventures
Corporate Round
$300,000,000
Jul 23, 2018
Corporate Round Investors
GSK
Series F
$250,000,000
Sep 4, 2017
Series F Investors
Sequoia Capital
Fidelity Investments
Euclidean Capital
Altimeter Capital
Wallenberg Foundations
Casdin Capital
G Squared
Nimble Ventures
Grant
$1,700,000
Oct 12, 2016
Grant Investors
National Institutes of Health (NIH)
Series E
$115,000,000
Oct 13, 2015
Series E Investors
WuXi Healthcare Ventures
Casdin Capital
Xfund
New Enterprise Associates (NEA)
MPM Capital
GV
EquityZen
Illumina Ventures
Lauder Partners
Grant
$1,400,000
Jul 28, 2014
Grant Investors
National Institutes of Health (NIH)
Series D
$50,000,000
Dec 20, 2012
Series D Investors
GV
Anne Wojcicki
Sergey Brin
New Enterprise Associates (NEA)
MPM Capital
Series C
$9,000,000
Jan 6, 2011
Series C Investors
Johnson & Johnson Development
MPM Capital
Series C
$22,220,289
Nov 8, 2010
Series C Investors
Johnson & Johnson Development
GV
New Enterprise Associates (NEA)
Series B
$13,600,000
Jun 17, 2009
Series B Investors
Google
Sergey Brin
New Enterprise Associates (NEA)
Series A
$8,953,320
Oct 2, 2007
Series A Investors
Google
New Enterprise Associates (NEA)
Mohr Davidow Ventures
Genentech
Stephens Investment Management
Wendi Deng Murdoch

Funding info provided by Diffbot.